European Investor
09 Apr 2026, 15:58
**Neogen Posts Q3 Loss Despite Stable Revenue, Raises Full-Year Outlook**
Neogen Corporation reported fiscal third-quarter 2026 revenue of $211.2 million, with modest growth in its Food Safety segment offset by a sharp decline in Animal Safety performance.
The company posted a net loss of $17.0 million, or $(0.08) per share, while adjusted net income reached $19.4 million, with adjusted EPS of $0.09. Adjusted EBITDA came in at $48.2 million, with margins improving to 22.8%.
Food Safety revenue increased 2.6%, supported by solid core growth, while Animal Safety revenue dropped 20.1%, primarily due to third-party supplier disruptions. Despite these challenges, Neogen generated operating cash flow of $22.7 million and free cash flow of $11.1 million.
The company said it remains on track with key strategic initiatives, including the Petrifilm manufacturing transition and the planned divestiture of its Genomics unit. Neogen also raised its full-year revenue outlook while maintaining its adjusted EBITDA guidance, signaling confidence in a recovery driven by operational improvements and cost controls.
Business Wire
Neogen Corporation reported fiscal third-quarter 2026 revenue of $211.2 million, with modest growth in its Food Safety segment offset by a sharp decline in Animal Safety performance.
The company posted a net loss of $17.0 million, or $(0.08) per share, while adjusted net income reached $19.4 million, with adjusted EPS of $0.09. Adjusted EBITDA came in at $48.2 million, with margins improving to 22.8%.
Food Safety revenue increased 2.6%, supported by solid core growth, while Animal Safety revenue dropped 20.1%, primarily due to third-party supplier disruptions. Despite these challenges, Neogen generated operating cash flow of $22.7 million and free cash flow of $11.1 million.
The company said it remains on track with key strategic initiatives, including the Petrifilm manufacturing transition and the planned divestiture of its Genomics unit. Neogen also raised its full-year revenue outlook while maintaining its adjusted EBITDA guidance, signaling confidence in a recovery driven by operational improvements and cost controls.
Business Wire
